Skip to main content

NCBiotech News

  • A Morehead City company using innovative materials to help restore North Carolina oyster habitats is among 11 finalists vying for $50,000 funding packages in the spring 2016 round of NC IDEA grants.
  • A dozen agricultural biotechnology companies from North Carolina, seven other states and even a European startup from Portugal will share their breakthrough technologies for crop and animal health advancements at the day-long Ag Biotech Entrepreneurial Showcase 2016 May 18 at the North Carolina Biotechnology Center.
  • FUJIFILM Diosynth Biotechnologies held a ribbon-cutting ceremony today to celebrate the opening of a 62,000-square-foot facility in Morrisville to house its bioprocess R&D groups.
  • Research Triangle Park-based medical diagnostics company BioMedomics has received approval from the Kenya Ministry of Health to sell Sickle SCAN, the company’s portable and quick-reporting test system for sickle cell disease (SCD) and sickle cell trait (SCT).
  • Plans for a new kind of agricultural technology startup company started to take shape today with the announcement of an $11.5 million AgTech Accelerator corporation in Research Triangle Park.
  • Bioscience briefs with names making news
  • One of the most significant incubators of small businesses in North Carolina is celebrating National Small Business Week with a visit from its district’s Congressman. And all four First Flight Venture Center (FFVC) startup companies making “Shark Tank”-type pitches to the audience are being bootstrapped with loans from the North Carolina Biotechnology Center.
  • Global generic drug maker Aurobindo Pharma said today it will invest over $31.7 million to establish a new national headquarters in Durham that will  bring 275 new R&D and pharmaceutical manufacturing jobs to the Triangle.
  • The North Carolina Biotechnology Center awarded 21 grants and loans totaling $2.5 million to companies, universities and nonprofit organizations across the state during the third quarter of its 2015-2016 fiscal year ending March 31.
  • Bioscience briefs with names making news
  • Two North Carolina companies are among 39 biotechnology firms competing in a Buzz of BIO contest to recognize the most innovative companies prior to this summer’s BIO International Convention in San Francisco, June 6-9.
  • Bayer's crop science division hosted more than 160 fifth graders and high school students from central North Carolina this week at its Research Triangle Park campus, letting the students tour facilities, talked with Bayer staff and participate in hands-on exercises demonstrating how new crop seeds and ag chemicals move from an idea in someone’s mind to a product used in a farmer’s field.
  • Durham’s Deep Blue Medical Advances, founded in 2014 by a plastic surgeon as an incubator for developing Duke medical device inventions, is the sole bioscience-related semifinalist in the spring 2016 round of NC IDEA grants.
  • A pioneering researcher at North Carolina State University, Rodolphe Barrangou, Ph.D., will tell the public Monday evening how he’s cutting and pasting his way to new discoveries in the adaptive bacterial immune system known as CRISPR.
  • Medical Murray is celebrating 20 years of innovation and expansion in the medical device industry on April 1, 2016, mere months after open house festivities at a new Medical Murray Southeast building near the Charlotte Douglas International Airport.
  • Novo Nordisk has officially begun building a $1.8 billion production facility for diabetes medicines at its Clayton site that will create 700 high-paying jobs, doubling its workforce there.
  • Morris Clarke, Ph.D., associate professor of biochemistry at Winston-Salem State University, has been named leader of the Executive Council of the Advisory Committee for Biotechnology in the Piedmont Triad as new members also join the advisory committee.
  • Duke University has purchased an exclusive sublicense from former NC biotech company PhaseBio Pharmaceuticals to use some of the firm's technology in developing long-acting cancer drugs with minimal toxic side effects.
  • Doug Edgeton, president and CEO of the North Carolina Biotechnology Center, is among a dozen corporate leaders nominated for a 2016 “Full Steam Ahead” award in a contest sponsored by WRAL TechWire.
  • Morrisville-based Envisia Therapeutics, a clinical-stage biotechnology company focused on developing novel therapies for eye diseases, has raised $16.5 million in additional Series A financing from existing investors.

Pages

Subscribe to News & Events